Study Title

Evaluating the Clinical Value of 68Ga-TCR-FAPI PET/CT to Guide the Surgical Treatment for Medullary Thyroid Carcinoma (MTC)

Study Details

Description:

Surgery remains the only curative option for MTC, yet the current imaging-based method (ultrasound, CT, MRI, 18F-FDG PET/CT) or calcitonin-based method are insufficient to map the extent of disease. In the previous studies, TCR-FAPI can covalently bind to FAP that increase tumor uptake and tumor retention, and better diagnosed MTC than the current radiotracers.

Sponsor:

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Contacts:

Shaoyan Liu, M.D.

shaoyanliu.bj@263.net

0086-010-87787190

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468